Although the CA125 test alone as a screening marker has been considered ineffective, the UKCTOCS study evaluated longitudinal measurements of CA125 levels for the screening of ovarian cancer in an algorithm termed ‘risk of ovarian cancer algorithm’ (ROCA) [19]. The gene discussed is MUC16; the disease is ovarian cancer.